GMGoldie Ann McQuaid

Goldie Ann McQuaid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Goldie Ann McQuaid has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anticholinergic Medications and Health in Adults with Autism or Intellectual Disability

    by Goldie A. McQuaid, Sha Tao, Lindsay L. Shea, Gregory L. Wallace

    Objective: Contributors to autistic adults’ elevated risk for negative aging-related outcomes, including Alzheimer’s disease and related dementias (ADRD), falls, and mortality remain underexplored. One candidate factor is exposure to medications with anticholinergic (AC) effects. Thus, this study assessed prevalence of medications with AC effects, and their associations with ADRD, falls, and mortality across four groups: autism-only, autism+intellectual disability (ID), ID-only, and controls. Methods: We conducted a retrospective cohort study of 2017-2019 US linked Medicare and Medicaid claims data for 40+ year-olds. Autism, ID, ADRD, and falls were identified using validated algorithms, and mortality was based on Medicare/Medicaid death indicators. Medications were coded using a comprehensive AC potency scale. AC medication exposure effects and interactions between AC potency and group were examined using modified Poisson regressions. Sensitivity analyses to address indication bias excluded persons prescribed antidepressant and/or antipsychotic medication(s). Results: All three clinical groups experienced significantly greater AC medication exposure (autism+ID: 92.5%>ID-only: 88.6%>autism-only: 80.0%) than non-autistic/non-ID controls (61.3%). Additionally, AC medications were more frequently associated with ADRD, falls, and mortality in all of these groups. Stepwise associations between AC potency levels and ADRD, falls, and mortality were found, and these effects were more prominent for persons with autism and/or ID relative to the control sample. Interpretation: This study provides a foundational examination of exposure to AC medication effects and their associations with aging-related outcomes in middle-age and older autistic adults and adults with ID. AC medication exposure represents one potential modifiable risk factor for negative aging-related outcomes in these groups.

  • Open Access

    Modifiable Factors Contributing to Adolescent Brain Development Begin in Utero and Infancy

    by Goldie A. McQuaid, Valerie L. Darcey, Diana Fishbein, Ashley S. VanMeter

    Adolescent brain development is not solely determined by factors occurring in adolescence but reaches back into the earliest stages of life: in utero and infancy. This chapter explores these two critical periods and modifiable factors that set the stage for the development of the adolescent brain. First, we describe the research related to maternal stress during pregnancy and the long-term effects that have been measured many years later. Second, we review how components of maternal diet and breastfeeding during infancy, and the associated benefits via intake of omega-3 fatty acids, a key nutritional component of breast milk, also lead to long-lasting developmental changes in the brain. Our goal in this chapter is to emphasize the importance of supporting mothers and families, given the long-lasting effects that the earliest parts of development have on healthy adolescent brain development.

  • Open Access

    Are Autistic Traits Elevated and Linked to Functional Outcomes Among People with Parkinson’s Disease?

    by Rachel Spransy, Goldie McQuaid, Gregory Wallace

    A growing body of research suggests a link between autism and parkinsonism, the set of motor symptoms associated with Parkinson’s disease (PD). Although prior studies report increased prevalence of parkinsonism symptoms among middle-aged and older autistic adults, limited research has explored the presence of autistic traits and their influence on real-world outcomes in people with PD. Therefore, the present study examined: (1) self-rated autistic traits using the Comprehensive Autistic Trait Inventory (CATI) in middle-aged and older adults with PD without a known autism diagnosis (n=164, 40-91 years) compared to a comparably aged neurotypical (NT) group (n=155, 40-88 years); (2) the onset of these autistic traits by querying whether endorsed traits were either always present, pre-existing but increasing, or newly emerging, and finally; (3) associations between autistic traits and key outcome metrics in PD. The PD and NT groups did not differ in their self-ratings of overall autistic traits; however, people with PD were more likely to endorse increasing autistic traits. Autistic trait ratings were associated with all key outcome metrics (i.e., motor and non-motor PD symptoms, mental health, subjective quality of life, activities of daily living, and subjective cognition) in the PD group. In particular, increasing autistic traits were linked to greater PD symptoms, lower subjective quality of life, greater anxiety symptoms, and increased reports of subjective cognitive decline. Although overall autistic traits were not elevated for people with PD, this group did report more pre-existing autistic traits that had increased, which were in turn linked to more detrimental functional outcomes.

  • Open Access

    Characterization of Anticholinergic Medication Use and Its Associations With Everyday Memory Problems and Cognitive Decline in Autistic Adults With Higher Support Needs

    by Goldie A. McQuaid, Nancy Raitano Lee, Gregory L. Wallace

    Among older adults in the general population, medications with anticholinergic (AC) effects are associated with declines in cognitive functioning and with dementia and Alzheimer's disease. Autistic people have high rates of co‐occurring medical conditions and polypharmacy across the lifespan; thus, they may be at particularly high risk of exposure to AC medications and their negative impacts on cognitive functioning, including earlier in adulthood. Consistent with this, a single study has shown AC medication use is prevalent among autistic adults without co‐occurring intellectual disability and is associated with self‐reported concurrent memory problems and declines in cognition. No study has examined AC medications and their associations with cognition among autistic adults with higher support needs. We therefore characterized AC medication use and its associations with caregiver‐rated memory problems and changes in cognition and behavior that have been linked with cognitive decline. Caregivers of autistic adults (18–68 years; Mean ~31 years) recruited via Simons Powering Autism Research's (SPARK) Research Match service reported medication use ( N = 512), memory complaints ( N = 467), and a screener that probes behavior/cognitive changes ( N = 466) that are associated with cognitive decline among persons with an intellectual disability. The majority (66.41%) of autistic adults were taking at least one AC medication and 31% were taking clinically‐meaningful levels of these medications. After controlling for age and birth sex, greater potency of AC medications was associated with both caregiver‐reported memory challenges and behavioral/cognitive changes associated with cognitive decline. Understanding AC medication use and its potential impacts on cognition among autistic adults with higher support needs is crucial.


  • Executive Functioning Is Linked to Internalizing Symptoms in Autistic Adults With Higher Support Needs

    by Ethan Greenstein, Nancy Raitano Lee, Goldie A. McQuaid, Gregory L. Wallace

    Executive function (EF) refers to a set of cognitive skills essential for self-regulation, problem-solving, and goal-directed behavior. Although EF’s relationship with co-occurring depression and anxiety symptoms is well documented in autistic individuals, particularly children without intellectual disability (ID), far less is known about this relationship in autistic adults with higher support needs, including those with ID. The present study addresses this gap by examining associations between three EF components (flexibility, emotion regulation, and inhibitory control) and symptoms of anxiety and depression in 486 autistic adults with higher support needs (ages 18–68; M = 31.07 years), recruited through the Simons Powering Autism Research for Knowledge (SPARK) Research Match service. Caregivers completed the Flexibility Scale, the Barkley Deficits in Executive Functioning Scale (inhibitory control and emotion regulation subscales), and the Anxiety, Depression, and Mood Scale (anxiety and depression subscales). Hierarchical linear regressions, controlling for age, sex assigned at birth, likely cognitive impairment, and caregiver educational attainment, revealed that greater difficulties with flexibility and emotion regulation were significantly associated with elevated anxiety and depression symptoms, whereas inhibitory control difficulties were not. These findings identify flexibility and emotion regulation as key correlates of internalizing symptoms in autistic adults with higher support needs, highlighting these domains as potential targets for future mechanistic and intervention research aimed at reducing anxiety and depression symptoms in this group. Lay Some everyday thinking skills help people manage feelings, handle change, and pause before acting. These are called executive functions. Most studies on these skills in autism have focused on children or on adults who do not have an intellectual disability, so autistic adults who need higher levels of support are often left out of research. In this study, caregivers answered questions about these thinking skills and about anxiety and depression for a large group of autistic adults with higher support needs, including people with intellectual disability. The results showed that greater challenges with flexibility and emotion regulation were linked with more anxiety and depression symptoms, suggesting that flexibility and emotion regulation could be an important focus for intervention development and support provision efforts aimed at reducing anxiety and depression symptoms in this group.

  • Open Access

    Emotion regulation strategy use, associations with depressive and anxious symptomatology, and sex-based differences in two independent samples of autistic adults

    by Goldie McQuaid, Allison Jack, Gregory Wallace

    Autistic adults experience elevated rates of depression and anxiety relative to neurotypical adults. Reasons for these elevated rates are not well understood. One possible factor is differences in emotion regulation (ER). ER has been studied largely in autistic youth samples and has not typically investigated sex differences in ER and its associations with depression and anxiety.This preregistered study examined associations between cognitive reappraisal (CR) and expressive suppression (ES) and depressive and anxious symptomatology, and the potential modulations of these associations by sex in autistic adults without co-occurring intellectual disability. Two independent samples of autistic adults (Sample 1: N=225, 18.6-31.5y; 70.7% female; Sample 2: N=267, 18-83y, 71.9% female) self-reported ER strategy use (CR in both samples; ES in Sample 1 only), and depressive and anxious symptomatology.No significant differences between male and female autistic adults in CR or ES use was found. Greater use of ES was significantly associated with higher levels of depressive and anxious symptomatology, and female sex was significantly associated with higher levels of these symptoms after accounting for ER strategy use in Sample 1. In Sample 2, no effect of sex was observed. We suggest ES may overlap with autistic masking and may have particular impacts on autistic people's wellbeing.

  • Open Access

    Shared and Unique Contributions of Interoceptive Confusion and Alexithymia to Sensory Processing Differences in Autism

    by Stefen Beeler-Duden, Sophie Lawson, Ishita Bakshi, Mirella Dapretto, Shulamite Green, Abha Gupta, Lauren Kenworthy, Goldie McQuaid, Jennifer MacCormack, Kevin Pelphrey, et al.

    Sensory processing differences are a core feature of autism, yet mechanisms underlying sensory distress remain incompletely understood. Emerging work suggests that interoceptive difficulties and alexithymia, reflecting uncertainty about bodily and emotional states, may be associated with sensory responsivity. The present study examined the independent and shared associations of interoceptive confusion and alexithymia with sensory processing differences in 69 autistic adolescents and young adults (M age = 20.92 years). Participants completed self-report measures of sensory responsivity (Glasgow Sensory Questionnaire; GSQ), interoceptive confusion (ISQ-8), and alexithymia (GAFS-8). In multiple regression analyses, both alexithymia (B = .42, p < .001) and interoceptive confusion (B = .36, p = .001) were independently associated with greater sensory processing differences, together accounting for approximately half of the variance (R² ≈ .49). Commonality analyses indicated that most explained variance was shared (~58%), alongside unique contributions from alexithymia (~24%) and interoceptive confusion (~18%). Associations were largely domain-general across sensory modalities and hyper- and hypo-responsivity dimensions. To our knowledge, this is the first study to partition shared and unique contributions of interoceptive confusion and alexithymia to sensory responsivity in autism. These findings support integrative accounts linking sensory processing differences to internal state uncertainty and highlight interoceptive and emotional awareness as dimensions relevant to sensory experience in autism.

  • Longitudinal Association Between Social Support and Quality of Life Among Middle-Aged and Older Autistic Adults

    by Wei Song, Goldie A. McQuaid, Rebecca A. Charlton, Gregory L. Wallace

    Social support is positively associated with quality of life (QoL) in autistic people, yet almost all evidence is cross-sectional and focused on younger adults. We examined 2-year longitudinal survey data from 209 autistic adults aged ⩾40 years living in the United States, all recruited via the Research Match service of Simons Powering Autism Research for Knowledge. Participants self-reported their general QoL, autism-specific QoL, and social support (subjective support, instrumental support, and social interaction). Cross-lagged panel models tested bidirectional associations. Mean scores increased from Time 1 to Time 2 for the general QoL and autism-specific QoL, while social support was mostly stable. Higher baseline general QoL predicted greater subjective support later, whereas baseline subjective support did not predict later general QoL. A reciprocal relationship emerged between autism-specific QoL and subjective support. Unexpectedly, baseline instrumental support predicted lower subsequent general QoL. Among autistic adults in mid-to-later life, QoL appears to drive subsequent social support more strongly than support drives QoL, with the clearest reciprocity observed for autism-specific QoL and subjective support. Future multiwave studies with more diverse samples are needed to chart long-term trajectories and determine how tailored support can optimize aging outcomes in individuals with autism. Lay We know little about how autistic people’s perceived social support and quality of life (QoL) influence each other as they age. We surveyed 209 40+-year-old autistic adults living in the United States at two timepoints 2 years apart. They answered questions about their general QoL, QoL specific to their autistic experiences, and three types of social support (subjective support, instrumental support, and social interaction). The first survey was in late 2019/early 2020, and the second was 2 years later – late 2021/early 2022. We found that, on average, middle-aged and older autistic adults reported better QoL after 2 years, while the amount of practical help and the number of social interactions did not change. People who started out with better QoL reported more subjective support later. Reporting better autism-specific QoL at the beginning led to more emotional and practical support later and vice versa – feeling well-supported emotionally initially led to better autism-specific QoL later. Surprisingly, getting more initial practical support was linked to lower overall QoL 2 years later. Our results suggest that helping autistic adults feel comfortable with their identity, manage sensory needs, and navigate services may not only improve their QoL but also strengthen the emotional and practical support they receive from others. Practical help is still important, but it should match the person’s goals and preferences, so that it boosts, rather than harms, life satisfaction. Programs that check in regularly about changing needs, especially around significant life events like retirement or health changes, could make a real difference as autistic adults grow older.


  • Latent Structure of the WHOQOL-BREF: Implications for Measuring Quality of Life Among Autistic Adults

    by Elizabeth A. Kaplan-Kahn, Goldie A. McQuaid, Nancy Raitano Lee, Gregory L. Wallace, Benjamin E. Yerys

    Background: To accurately measure quality of life among autistic adults, researchers need surveys that are psychometrically validated for autistic populations. Researchers have demonstrated that the short version of the World Health Organization Quality of Life instrument (WHOQOL-BREF) has strong psychometric properties in the general population. Although there has been some research exploring basic psychometric properties (reliability, convergent validity, etc.) of the WHOQOL-BREF in autistic populations, the underlying latent structure of the measure has not been tested in autistic adults. Our goal in the current study was to compare different confirmatory factor analysis (CFA) models to test which one best captured the underlying latent structure of the WHOQOL-BREF data in a sample of autistic adults. Methods: A total of 842 autistic adults between the ages of 18 and 83 years completed the WHOQOL-BREF. Based on participant responses, we compared four a priori CFA models—correlated four-factor, unidimensional, higher-order, and bifactor models—to demonstrate which model structure best captures the underlying latent structure of the measure in this population. Results: Similar to past research, the WHOQOL-BREF showed strong internal reliability in our sample of autistic adults. The bifactor model demonstrated the best fit to the data—demonstrating that the WHOQOL-BREF is best conceptualized as having both domain-specific quality-of-life factors (i.e., the Physical, Psychological, Environmental, and Social domains of the WHOQOL-BREF) and a general quality-of-life factor. Conclusion: Our results provide researchers with psychometric validation of the underlying latent structure of the WHOQOL-BREF in autistic populations. Items on the WHOQOL-BREF capture both domain-specific and general quality of life among autistic adults. Researchers can use the bifactor model to accurately capture multiple dimensions of quality of life in autistic adults, advancing the ways that the WHOQOL-BREF can be used as a measure of quality of life among autistic people.


  • Open Access

    Elucidating the structure of depressive symptoms, emotion regulation, and their interrelatedness in autistic adults: A network analysis

    by Goldie A. McQuaid, Nancy Raitano Lee, Gregory L. Wallace

    Relative to the general population, autistic adults are at elevated risk for depression. Factors related to this risk are poorly understood, yet identifying such factors is important for improving mental health in autistic people. Emotion regulation (ER) challenges may be one such factor. However, few studies have examined ER challenges and depression in autistic adults. We examined ER challenges, depressive symptomatology and their associations in 775 (aged 18–83 years) autistic adults using network analysis, a method that permits identification of key components of ER and depression and their interrelatedness. Three non-regularized weighted undirected networks were estimated: ER challenges, depressive symptomatology, and combined ER-depressive challenges. Community structures revealed in the ER challenges and depressive symptomatology networks align with theoretical/nosological models of ER challenges/depressive symptoms as well as extant research using network analysis to examine these constructs. The combined ER challenges-depressive symptomatology network indicated that ER challenges and depressive symptomatology are interrelated but distinct constructs. These preliminary findings using cross-sectional data provide a first step in understanding associations between a candidate factor in depression vulnerability in autistic adults – ER challenges – and identify important future research directions.